THIENOPYRIMIDINES AS COOLING AGENTS

(19)

(11)

EP 1 817 000 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	15.04.2009 Bulletin 2009/16

(45)	Mention of the grant of the patent:
	31.12.2008 Bulletin 2009/01

(21)	Application number: 05803655.9

(22)	Date of filing: 07.11.2005

(51)

International Patent Classification (IPC):

A61K 8/49^(2006.01)

(86)	International application number:
	PCT/EP2005/011972

(87)	International publication number:
	WO 2006/058600 (08.06.2006 Gazette 2006/23)

(54)	THIENOPYRIMIDINES AS COOLING AGENTS THIENOPYRIMIDINE ALS KÜHLMITTEL UTILISATION DE THIENOPYRIMIDINES COMME AGENTS REFROIDISSANTS

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30)

Priority:

30.11.2004 GB 0426266

(43)	Date of publication of application:
	15.08.2007 Bulletin 2007/33

(73)	Proprietors:
	Unilever PLC London EC4Y 0DY (GB) Designated Contracting States: CY GB IE Unilever N.V. 3013 AL Rotterdam (NL) Designated Contracting States: AT BE BG CH CZ DE DK EE ES FI FR GR HU IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(72)	Inventors:
	FOSTER, Alison Jayne, Unilever R & D Port Sunlight Wirral Merseyside CH63 3JW (GB) VAN DER LOGT, Cornelis Paul Erik NL-3133 AT Vlaardingen (NL) LOURBAKOS, Afrodite, Unilever R & D Vlaardingen NL-3133 AT Vlaardingen (NL) TAREILUS, Erwin Werner, Unilever R & D Vlaardingen NL-3133 AT Vlaardingen (NL)

(74)	Representative: Hugot, Alain et al
	Unilever Patent Group Colworth House Sharnbrook Bedford, MK44 1LQ Colworth House Sharnbrook Bedford, MK44 1LQ (GB)

(56)

References cited: :

WO-A-20/04072074

DATABASE BEILSTEIN [Online] Beilstein Institut zur Förderung der Chemischen Wissenschaften; XP002365034 retrieved from STN Database accession no. 7761696,7762833,7764466 & Z. A. HOZIEN ET AL.: "Synthesis of some biologically active agents derived from thieno[2,3-d]pyrimidine derivatives" PHARMAZIE, vol. 52, no. 10, 1997, pages 753-758, cited in the application
R. ANDERSKEWITZ ET AL.: "Pyrrolidinohydroquinazolines - a novel class of CCR3 modulators" BIOORG. MED. CHEM. LETT., vol. 15, no. 3, 9 December 2004 (2004-12-09), pages 669-673, XP002364991

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).